Connective tissue diseases (CTDs) are a group of serious autoimmune disorders that often affect multiple organs—skin, joints, kidneys, lungs, blood vessels, muscles, and the nervous system. These diseases are challenging to treat, but with expert care and access to targeted biologic therapy at a physician-led Infusion Center, patients can experience life-changing results.
Infusion Care for Autoimmune Diseases
Cohen Medical Center delivers specialized, high-level care to patients with Systemic Lupus Erythematosus (SLE), Systemic Sclerosis, Myositis, MCTD, Sjogren’s, APS, and more—using advanced infusion protocols tailored to each individual case. Every therapy is administered, monitored, and optimized at his full-service Infusion Center.
Comprehensive Infusion Therapy at the INFUSION CENTER for the Following CTDs:
- Systemic Lupus Erythematosus (SLE)
- Systemic Sclerosis (Scleroderma)
- Polymyositis
- Dermatomyositis
- Mixed Connective Tissue Disease (MCTD)
- Sjogren’s Syndrome
- Antiphospholipid Syndrome (APS)
- Undifferentiated Connective Tissue Disease (UCTD)
These conditions require precision, close monitoring, and fast access to treatment—services available directly at Cohen Medical Center, where infusion-based care is delivered with speed and clinical accuracy.
Infusion Therapies for CTDs Administered at the INFUSION CENTER
Dr. Cohen uses a range of targeted infusion therapies at the Infusion Center, including:
- RITUXAN (IV infusion) – A B-cell depleting therapy widely used for SLE, MCTD, Sjogren’s, UCTD, and myositis, administered under supervision at the Infusion Center.
- BENLYSTA (IV infusion) – The only FDA-approved biologic for SLE, shown to reduce flares and steroid use, delivered at the Infusion Center.
- SAPHNELO (IV infusion) – A breakthrough IV treatment for moderate-to-severe SLE, now offered at the Infusion Center as part of Dr. Cohen’s lupus protocol.
- ACTEMRA (IV infusion) – Used for select cases of Systemic Sclerosis and autoimmune overlap syndromes at the Infusion Center.
- IVIG (Intravenous Immunoglobulin) – Administered for Polymyositis, Dermatomyositis, SLE, APS, and Sjogren’s at the Infusion Center, especially when standard treatments fail.
- Methylprednisolone (IV pulse therapy) – Given at the Infusion Center during severe flares in SLE, MCTD, UCTD, and Dermatomyositis.
INFUSION CENTER Services for Connective Tissue Disease Patients
At Cohen Medical Center, patients benefit from:
- Immediate access to RITUXAN, BENLYSTA, SAPHNELO, ACTEMRA, IVIG, and IV steroids
- Prompt scheduling for new patients and those in flare
- Comfortable private rooms within the Infusion Center
- Continuous oversight by Dr. Cohen and infusion-trained nursing staff
- Onsite labs and real-time treatment adjustments
- Infusion education and full care coordination—all within the Infusion Center
Everything is built around safety, comfort, and clinical excellence—hallmarks of Cohen Medical Center.
Tailored Infusion Protocols at the INFUSION CENTER for SLE, Scleroderma, Myositis & More
All infusion therapy plans at the Infusion Center are tailored by Dr. Cohen based on disease markers, antibody profiles, and organ involvement. The Infusion Center team supports patients throughout protocols designed to treat:
- Lupus nephritis, cutaneous lupus, or systemic SLE flares
- ILD from Systemic Sclerosis or MCTD
- Muscle weakness in Polymyositis or Dermatomyositis
- Resistant symptoms in Sjogren’s or UCTD
- High-risk vascular features in Antiphospholipid Syndrome
These conditions require advanced infusion care—delivered precisely at Cohen Medical Center.
Powerful Patient Outcomes, Delivered at the INFUSION CENTER
With early intervention and expert infusion-based therapy, patients at Cohen Medical Center commonly achieve:
- Reduced disease activity and flare frequency
- Regained muscle strength and function
- Safe tapering off chronic steroids
- Improved kidney and lung metrics
- Normalized autoimmune labs
- Enhanced energy, cognition, and daily life quality
These results happen because the Infusion Center operates as more than just a treatment site—it’s a hub of integrated, expert autoimmune care.
Cohen Medical Center: Your Regional Leader in CTD Infusion Therapy
Patients and referring physicians turn to Cohen Medical Center for RITUXAN, BENLYSTA, SAPHNELO, ACTEMRA Infusions, IVIG Administration, and IV Methylprednisolone Therapy Whether managing SLE, scleroderma, myositis, MCTD, or UCTD, the care you receive at the Infusion Center is comprehensive, compassionate, and deeply informed by clinical experience. Contact Cohen Medical Center today to learn more or schedule a consultation—and take the first step toward personalized, expert care.
